{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T20:10:36Z","timestamp":1779307836857,"version":"3.51.4"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009927","name":"Fidia Farmaceutici SpA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009927","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Open Science"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.euros.2026.03.004","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T15:01:43Z","timestamp":1775055703000},"page":"25-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A Study to Evaluate Efficacy and Safety of Hydeal Cyst Intravesical Instillations in Non\u2013muscle Invasive Bladder Cancer Patients Treated With Intravesical Chemotherapy or Immunotherapy"],"prefix":"10.1016","volume":"87","author":[{"given":"Francesco","family":"Callegarin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Amodeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Claps","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Crestani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gian Maria","family":"Busetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio","family":"Dal Moro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Zanovello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Pavan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Magni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Buran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Di Gianfrancesco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gian Luca","family":"De Salvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Porreca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euros.2026.03.004_b0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.euros.2026.03.004_b0010","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/bju.14557","article-title":"Surgical checklist impact on recurrence-free survival of patients with non-muscle-invasive bladder cancer undergoing transurethral resection of bladder tumor","volume":"123","author":"Suarez-Ibarrola","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.euros.2026.03.004_b0015","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.eururo.2020.04.059","article-title":"An international collaborative consensus statement on en bloc resection of bladder tumor incorporating two systematic reviews, a two-round Delphi survey, and a consensus meeting","volume":"78","author":"Teoh","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.03.004_b0020","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.eururo.2024.07.027","article-title":"European Association of Urology guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ)-A summary of the 2024 guidelines update","volume":"86","author":"Gontero","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.03.004_b0025","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.eururo.2019.08.016","article-title":"European Association of Urology guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ) - 2019 update","volume":"76","author":"Babjuk","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.03.004_b0030","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.eururo.2014.09.026","volume":"67","author":"Solsona","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.03.004_b0035","article-title":"Intravesical Bacillus Calmette-Gu\u00e9rin (BCG) treatment\u2019s severe complications: a single institution review of incidence, presentation and treatment outcome","volume":"19","author":"Waked","year":"2020","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"10.1016\/j.euros.2026.03.004_b0040","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.euo.2024.12.013","article-title":"A systematic review and meta-analysis of the clinical impact of prophylactic quinolones with adjuvant Bacillus Calmette-Gu\u00e9rin instillation for non-muscle-invasive bladder cancer","volume":"8","author":"Wong","year":"2025","journal-title":"Eur Urol Oncol"},{"issue":"1","key":"10.1016\/j.euros.2026.03.004_bib76","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.eururo.2013.07.021","volume":"65","author":"Brausi","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.03.004_b0045","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1023\/A:1019507104741","article-title":"Intravesical treatment of severe bacillus Calmette-Guerin cystitis","volume":"33","author":"Palou","year":"2001","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.euros.2026.03.004_b0050","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.euf.2025.04.033","article-title":"Long-term oncological outcomes for patients with non-muscle-invasive bladder cancer treated with Bacillus Calmette-Gu\u00e9rin (BCG): a comparative analysis of adequate versus inadequate BCG treatment","volume":"12","author":"Scilipoti","year":"2025","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euros.2026.03.004_b0055","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1590\/s1677-5538.ibju.2015.0588","article-title":"Safety and efficacy of intravesical alum for intractable hemorrhagic cystitis: a contemporary evaluation","volume":"42","author":"Westerman","year":"2016","journal-title":"Int Braz J Urol"},{"issue":"Suppl. 2","key":"10.1016\/j.euros.2026.03.004_b0060","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.21037\/tau.2017.06.09","article-title":"Non-surgical management of recurrent urinary tract infections in women","volume":"6","author":"Bergamin","year":"2017","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.euros.2026.03.004_b0065","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.3390\/pharmaceutics13091450","article-title":"Synergy of Hydeal-D and hyaluronic acid for protecting and restoring urothelium: in vitro characterization","volume":"13","author":"Ruggeri","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.euros.2026.03.004_b0070","unstructured":"European Association of Urology. Guidelines-on-Non-muscle-Invasive-BC-2025.pdf. https:\/\/d56bochluxqnz.cloudfront.net\/documents\/full-guideline\/EAU-Guidelines-on-Non-muscle-Invasive-BC-2025.pdf."},{"key":"10.1016\/j.euros.2026.03.004_b0075","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1471-2490-14-64","article-title":"Could hyaluronic acid (HA) reduce Bacillus Calmette-Gu\u00e9rin (BCG) local side effects? Results of a pilot study","volume":"14","author":"Topazio","year":"2014","journal-title":"BMC Urol"}],"container-title":["European Urology Open Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168326000479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168326000479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T19:46:17Z","timestamp":1779306377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666168326000479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":16,"alternative-id":["S2666168326000479"],"URL":"https:\/\/doi.org\/10.1016\/j.euros.2026.03.004","relation":{},"ISSN":["2666-1683"],"issn-type":[{"value":"2666-1683","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Study to Evaluate Efficacy and Safety of Hydeal Cyst Intravesical Instillations in Non\u2013muscle Invasive Bladder Cancer Patients Treated With Intravesical Chemotherapy or Immunotherapy","name":"articletitle","label":"Article Title"},{"value":"European Urology Open Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euros.2026.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}